dysula的部落格

State Street said on
Friday it had no formal plans to overhaul the WM/Reuters foreign

Vision Solutions' Double-Take 7.1 Release Delivers New DR Capabilities and Improved Performance for Migrations, High Availability and Disaster Recovery

Defense lawyers for a friend of the accused Boston Marathon bomber charged with lying to investigators turned the spotlight on marijuana culture on Wednesday as they began to present their case that their client was too high to have been able to lie.

The first defense witness called to testify on behalf of Robel Phillipos, 21, who is charged with lying to the FBI about a visit to the suspected bomber's college dorm room three days after the attack that killed three people and injured more than 260, said he spent much of the day of the visit smoking marijuana with the defendant. At one point they got into a car to contain the cloud of smoke, he said.

HENDERSON, Nev., Sept. 10, 2014 (GLOBE NEWSWIRE) -- via PRWEB - Quest Solution, Inc, "The Company" (OTCBB: QUES), is pleased to announce under an irrevocable, perpetual and exclusive worldwide right and license, the acquisition of a Rebar Inspection technology for Bridges, Buildings and Tarmacs. The license, acquired from Rampart Detection Systems, will be held in the Company's recently formed Intellectual Property Division which has announced gun safety, mining technology, and aviation safety additions since its inception in early August.

Acquia Bolsters Executive Team, Names Bill Sorenson Chief Financial Officer

Greek Prime Minister Antonis Samaras comfortably won a confidence vote aimed at rallying support for his plan to abandon a widely-reviled EU/IMF aid package and ending speculation that his government is on its last legs.

Having endured party defections, riots and various government crises in his nearly two and half years in office, Samaras could face the prospect of snap polls if he fails to push through his candidate in a presidential election in early 2015.

Canada's main stock index fell
on Wednesday as telecoms and BlackBerry led the declines

SAN DIEGO, CA, Sep 04 (Marketwire) --
Startup PlayMG(TM) Corp., makers of MG(TM) -- the first dedicated

(in billion rupees)

GENEVA, Sept. 9, 2014 (GLOBE NEWSWIRE) -- STMicroelectronics (NYSE:STM), a global semiconductor leader serving customers across the spectrum of electronics applications, the world's top MEMS (Micro-Electro-Mechanical Systems) manufacturer and the leading supplier of MEMS for consumer and mobile applications1, today announced its development of the first iNEMO(TM) Ultra product - an always-on, high-performance 6-axis combination accelerometer and gyroscope that sets new standards for device and system power efficiency, signal noise, and performance in motion sensors. In concert with ST's ultra-low-power STM32 Microcontrollers, the LSM6DS3 combos will create new possibilities for the development of battery-powered smart sensor systems to be embedded in mobile and wearable devices and innovative objects for the Internet of Things (IoT).

France's Danone
, battling local rivals for a larger share of China's

SAN DIEGO, Sept. 22, 2014 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer and age-related macular degeneration, today announced the successful completion of a $27 million Series B financing. The financing round included new investors New Enterprise Associates (NEA), BioMed Ventures, and an additional institutional investor. The financing also included participation from all existing investors including JAFCO Co. Ltd., Nextech Invest Ltd., Brookline Investments, Arcus Ventures and BHP. MTS Health Partners and Wells Fargo Securities acted as placement agents for the financing. Sheppard Mullin acted as legal advisor to TRACON. As part of the Series B financing, Paul Walker of NEA will join the TRACON board of directors and Bruce Steel of BioMed Ventures will join as a board observer. Paul Walker is a partner in NEA's Menlo Park Office. He is a board observer of Sunesis and Interleukin Genetics, a former board member of TESARO (Nasdaq:TRSO), and manages a number of NEA's other late-stage and public investments. Mr. Walker received a Bachelor of Science in Biochemistry and Cell Biology from the University of California at San Diego, and holds the Chartered Financial Analyst designation. Bruce Steel is the Managing Director of BioMed Ventures, the strategic investment arm of BioMed Realty (NYSE:BMR). Previously he served in senior operating roles at several leading San Diego-based biotechnology companies. Mr. Steel received a Bachelor of Arts degree from Dartmouth College and a Master of Business Administration degree from the Marshall School of Business at the University of Southern California, and holds the Chartered Financial Analyst designation. TRACON also announced the appointment of Patricia Bitar as Chief Financial Officer. From November 2009 until April 2014, Ms. Bitar served in roles of increasing responsibility at NuVasive, Inc., a medical device company, serving most recently as Vice President and Corporate Controller. From 2008 to October 2009 and during various periods of 1998 to 2006, Ms. Bitar provided independent financial consulting for a variety of companies, primarily in the biotechnology and electronics industries. From 2006 to 2008, Ms. Bitar served as the Senior Director of Financial Reporting and Corporate Controller at Orexigen Therapeutics, Inc., a biopharmaceutical company. From 1984 to 1991 and 1994 to 1998, she worked in the Audit Department at Ernst & Young. Ms. Bitar is a certified public accountant and received an M.A.I.S. from the University of West Florida and a B.S. in Business Administration (Accounting) from Old Dominion University.